Literature DB >> 22387085

Hyperthermia and multiorgan failure after abuse of "bath salts" containing 3,4-methylenedioxypyrovalerone.

Heather A Borek1, Christopher P Holstege.   

Abstract

"Bath salts" are being increasingly used as drugs of abuse. These products have been found to contain a variety of compounds, including 3,4-methylenedioxypyrovalerone (MDPV). We present a case of a 25-year-old man who injected bath salts and acutely developed severe agitation, hyperthermia, and tachycardia. Despite aggressive early medical management, including dialysis, he progressed to multiorgan system failure, although he ultimately recovered after a prolonged hospital course. The only chemical substance detected on comprehensive toxicologic testing was MDPV, a synthetic cathinone analogue. According to our case, MDPV abuse may result in adverse multisystem organ effects, including rhabdomyolysis, cardiac injury, hepatic injury, and renal failure. It is unknown whether these end-organ effects were due to direct cellular toxicity induced by MDPV or a result of the patient's marked agitation and hyperthermia. Acute management should focus on the rapid identification of organ injury and appropriate supportive care.
Copyright © 2012. Published by Mosby, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22387085     DOI: 10.1016/j.annemergmed.2012.01.005

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  52 in total

1.  Contrasting effects of d-methamphetamine, 3,4-methylenedioxymethamphetamine, 3,4-methylenedioxypyrovalerone, and 4-methylmethcathinone on wheel activity in rats.

Authors:  Pai-Kai Huang; Shawn M Aarde; Deepshikha Angrish; Karen L Houseknecht; Tobin J Dickerson; Michael A Taffe
Journal:  Drug Alcohol Depend       Date:  2012-06-03       Impact factor: 4.492

Review 2.  Bath salts and synthetic cathinones: an emerging designer drug phenomenon.

Authors:  Christopher L German; Annette E Fleckenstein; Glen R Hanson
Journal:  Life Sci       Date:  2013-08-02       Impact factor: 5.037

3.  Novel psychoactive substances: a novel clinical challenge.

Authors:  Christopher Daniel Smith; Margaret Williams; Maliha Shaikh
Journal:  BMJ Case Rep       Date:  2013-08-20

4.  Intoxications associated with agitation, tachycardia, hypertension, and Fever: differential diagnosis, evaluation, and management.

Authors:  Christopher J Keary; Shamim H Nejad; J J Rasimas; Theodore A Stern
Journal:  Prim Care Companion CNS Disord       Date:  2013-05-16

5.  Validation of the only commercially available immunoassay for synthetic cathinones in urine: Randox Drugs of Abuse V Biochip Array Technology.

Authors:  Kayla N Ellefsen; Sébastien Anizan; Marisol S Castaneto; Nathalie A Desrosiers; Thomas M Martin; Kevin L Klette; Marilyn A Huestis
Journal:  Drug Test Anal       Date:  2014-03-21       Impact factor: 3.345

Review 6.  Synthetic cathinones ("bath salts").

Authors:  Matthew L Banks; Travis J Worst; Daniel E Rusyniak; Jon E Sprague
Journal:  J Emerg Med       Date:  2014-02-22       Impact factor: 1.484

7.  Effects of orally self-administered bath salt constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice.

Authors:  Brenda M Gannon; Lauren N Russell; Meet S Modi; Kenner C Rice; William E Fantegrossi
Journal:  Drug Alcohol Depend       Date:  2017-08-04       Impact factor: 4.492

8.  Synthetic psychoactive cathinones: hypothermia and reduced lethality compared to methamphetamine and methylenedioxymethamphetamine.

Authors:  Dawn E Muskiewicz; Federico Resendiz-Gutierrez; Omar Issa; F Scott Hall
Journal:  Pharmacol Biochem Behav       Date:  2020-02-12       Impact factor: 3.533

9.  Binge-like acquisition of α-pyrrolidinopentiophenone (α-PVP) self-administration in female rats.

Authors:  Mehrak Javadi-Paydar; Eric L Harvey; Yanabel Grant; Sophia A Vandewater; Kevin M Creehan; Jacques D Nguyen; Tobin J Dickerson; Michael A Taffe
Journal:  Psychopharmacology (Berl)       Date:  2018-06-16       Impact factor: 4.530

10.  In vivo toxicometabolomics reveals multi-organ and urine metabolic changes in mice upon acute exposure to human-relevant doses of 3,4-methylenedioxypyrovalerone (MDPV).

Authors:  Ana Margarida Araújo; Márcia Carvalho; Vera Marisa Costa; José Alberto Duarte; Ricardo Jorge Dinis-Oliveira; Maria de Lourdes Bastos; Paula Guedes de Pinho; Félix Carvalho
Journal:  Arch Toxicol       Date:  2020-11-19       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.